Cancer 2025

Patricia Tai speaker at 3rd International Conference on Innovations and Advances in Cancer Research and Treatment
Keynote Presentation

Update on PSMA PET scans: initial and salvage treatment of nodal/distant metastases in prostate cancer

Patricia Tai University of Saskatchewan, Canada

This update explores prostate-specific membrane antigen (PSMA) positron-emission t [....] Read More

Amit Kumar Singh speaker at 3rd International Conference on Innovations and Advances in Cancer Research and Treatment
Oral Presentation

3D Organoid Modeling Reveals How Host-Microbiota Interactions Fuel Skin Cancer in the Context of TLR4 Deficiency and Epithelial IKKa Reduction

Amit Kumar Singh National Cancer Institute, USA

Introduction
Pattern recognition receptors (PRRs), such as Toll-like receptor 4 (TLR4), detect pa [....] Read More

Melinda Hysenaj speaker at 3rd International Conference on Innovations and Advances in Cancer Research and Treatment
Oral Presentation

Oncologic Emergencies: A Narrative Review with Clinical Cases and Recommendations

Melinda Hysenaj University of Prishtina, Albania

Background:
Oncologic emergencies are acute, life-threatening complications in cancer patients, including metabolic, [....] Read More

Melisa Stublla speaker at 3rd International Conference on Innovations and Advances in Cancer Research and Treatment
Oral Presentation

Incidents and near-misses in patient care

Melisa Stublla University of Prishtina, Albania

Background:
Near misses and adverse events in healthcare often result from communication [....] Read More

Yasmeen Idrees speaker at 3rd International Conference on Innovations and Advances in Cancer Research and Treatment
Oral Presentation

Beyond Relief: Opioid Use Disorder in Cancer Patients - Narrative Review and Expert Opinion

Yasmeen Idrees Fatima Jinnah Medical University, Pakistan

Opioids are vital for managing cancer-related pain, especially in advanced disease stages. However, [....] Read More

Hope C Ball speaker at 3rd International Conference on Innovations and Advances in Cancer Research and Treatment
Poster Presentation (Virtual)

Epigenetic Silencing of RIPK3 augments chemoresistance in pediatric osteosarcoma

Hope C Ball Akron Children’s Hospital, USA

Osteosarcoma (OS) is the most common high-grade malignant primary bone tumor in children and adolesc [....] Read More